Advertisement
Singapore markets open in 8 hours 47 minutes
  • Straits Times Index

    3,300.04
    -3.15 (-0.10%)
     
  • S&P 500

    5,196.83
    +16.09 (+0.31%)
     
  • Dow

    38,911.34
    +59.07 (+0.15%)
     
  • Nasdaq

    16,394.80
    +45.55 (+0.28%)
     
  • Bitcoin USD

    63,830.80
    +234.63 (+0.37%)
     
  • CMC Crypto 200

    1,321.24
    -43.88 (-3.21%)
     
  • FTSE 100

    8,313.67
    +100.18 (+1.22%)
     
  • Gold

    2,321.30
    -9.90 (-0.42%)
     
  • Crude Oil

    78.51
    +0.03 (+0.04%)
     
  • 10-Yr Bond

    4.4230
    -0.0660 (-1.47%)
     
  • Nikkei

    38,835.10
    +599.03 (+1.57%)
     
  • Hang Seng

    18,479.37
    -98.93 (-0.53%)
     
  • FTSE Bursa Malaysia

    1,605.68
    +8.29 (+0.52%)
     
  • Jakarta Composite Index

    7,123.61
    -12.28 (-0.17%)
     
  • PSE Index

    6,618.58
    -33.91 (-0.51%)
     

Is the IQOS Import Ban a Fatal Blow to Altria?

Is the IQOS Import Ban a Fatal Blow to Altria?

The U.S. International Trade Commission recently ruled Philip Morris International's (NYSE: PM) IQOS heated tobacco device violates two patents held by rival British American Tobacco (NYSE: BTI) and that the electronic cigarettes can't be imported or sold in the U.S. While the ruling is obviously a major blow to the tobacco giant because the U.S. is potentially the world's biggest, most lucrative market for e-cigs and IQOS is so far the only e-cig that has earned a modified-risk label from the Food and Drug Administration, the decision is a devastating blow to Philip Morris partner Altria (NYSE: MO) because it has no vapor products to fall back on and no other markets it can sell into.